Germany leads European healthcare expenditure on prescribed medicines with €57.52 billion in 2024, followed distantly by France and the UK with €32.61 billion and €16.19 billion, respectively. These values have seen moderate year-on-year increases, with Germany showing a 3.63% rise, France 1.06%, and the UK a marginal 0.22%. Switzerland, at €6.98 billion, enjoys a high growth rate of 4.95%, while smaller markets like Malta and Cyprus are seeing explosive increases, 11.71% and 22.1% respectively. Among the top economies, growth rates have been relatively modest, reflective of mature markets with established healthcare systems.
Future trends to watch include increasing digital healthcare solutions, which may alter the dynamics of pharmaceutical expenditures. Integration of AI for personalized medicine, evolving regulations around drug pricing and reimbursement, and potential shifts in pharmaceutical supply chains due to economic and political factors will likely play significant roles in shaping European healthcare expenditures in the coming years.
Top countries in Healthcare Expenditure on Prescribed Medicines by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 57,520 | 2023 | +2.67% | +3.63% | View data |
| 2 | 2 France | 32,610 | 2023 | +0.89% | +1.06% | View data |
| 3 | 3 United Kingdom | 16,190 | 2023 | -0.12% | +0.22% | View data |
| 4 | 4 Spain | 14,260 | 2023 | +3.38% | +2.99% | View data |
| 5 | 5 Switzerland | 6,980 | 2023 | +3.55% | +4.95% | View data |
| 6 | 6 Belgium | 5,030 | 2023 | +1.03% | +1.49% | View data |
| 7 | 7 Austria | 4,420 | 2023 | +2.94% | +3.98% | View data |
| 8 | 8 Sweden | 3,820 | 2023 | +1.58% | +1.48% | View data |
| 9 | 9 Poland | 3,050 | 2023 | +0.81% | +0.66% | View data |
| 10 | 10 Hungary | 2,790 | 2023 | +5.97% | +4.04% | View data |
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
